Suppression of interleukin-12 production by human monocytes after preincubation with lipopolysaccharide.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 10477697)

Published in Blood on September 01, 1999

Authors

M Wittmann1, V A Larsson, P Schmidt, G Begemann, A Kapp, T Werfel

Author Affiliations

1: Hannover Medical University, Department of Dermatology and Allergology, Hannover, Germany.

Articles by these authors

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol (2000) 9.70

BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol (2000) 6.04

EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy (2009) 4.10

EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy (2009) 3.86

A general enhancement scheme in heteronuclear multidimensional NMR employing pulsed field gradients. J Biomol NMR (1994) 3.16

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy (2014) 3.10

Primary prevention of food allergy in children and adults: systematic review. Allergy (2014) 2.75

The diagnosis of food allergy: a systematic review and meta-analysis. Allergy (2013) 2.23

Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients. Br J Dermatol (2005) 2.09

Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. FASEB J (2000) 2.09

EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy (2014) 2.05

Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology (2007) 2.02

The epidemiology of food allergy in Europe: a systematic review and meta-analysis. Allergy (2013) 2.02

The yeast NuA4 and Drosophila MSL complexes contain homologous subunits important for transcription regulation. J Biol Chem (2000) 1.92

Free energy change of ATP-hydrolysis: a causal factor of early hypoxic failure of the myocardium? J Mol Cell Cardiol (1982) 1.90

Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol (1989) 1.87

Standardization of food challenges in patients with immediate reactions to foods--position paper from the European Academy of Allergology and Clinical Immunology. Allergy (2004) 1.81

Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy (2006) 1.80

Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol (2012) 1.77

Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy (2014) 1.73

The muscleblind gene participates in the organization of Z-bands and epidermal attachments of Drosophila muscles and is regulated by Dmef2. Dev Biol (1998) 1.71

A dihydroxyboryl-substituted methacrylic polymer for the column chromatographic separation of mononucleotides, oligonucleotides, and transfer ribonucleic acid. Biochemistry (1973) 1.62

Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol (2002) 1.62

EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy (2006) 1.55

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy (2006) 1.54

A subset of CD8+ T cells from allergic patients produce IL-4 and stimulate IgE production in vitro. Clin Exp Allergy (1997) 1.51

The nosologic status of the remitting atypical psychoses. Compr Psychiatry (1989) 1.50

Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol (2012) 1.49

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology (1998) 1.48

Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. Ann Oncol (2000) 1.48

Soluble E-selectin in sera of patients with atopic dermatitis and psoriasis--correlation with disease activity. Br J Dermatol (1996) 1.46

The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy (2004) 1.42

Novel neutrophil chemotactic factor derived from human peripheral blood mononuclear leucocytes. Clin Exp Immunol (1986) 1.40

Comparison of Prenatal Risk Calculation (PRC) with PIA Fetal Database software in first-trimester screening for fetal aneuploidy. Ultrasound Obstet Gynecol (2009) 1.40

[Fatal post-traumatic alcohol delirium--compensation responsibility in private accident insurance?]. Versicherungsmedizin (1997) 1.39

[Atopic dermatitis. Version (17 July 2002 - modified final version)]. J Dtsch Dermatol Ges (2003) 1.39

Detection of deep venous thrombi and pulmonary embolus with technetium-99m-DD-3B6/22 anti-fibrin monoclonal antibody Fab' fragment. J Nucl Med (1994) 1.39

[SAPHO syndrome. Case description of 3 patients with acne conglobata and osteoarticular symptoms]. Hautarzt (1997) 1.38

Recovery of kidney function following prolonged acute renal failure. Proc Eur Dial Transplant Assoc (1979) 1.38

Increased metal allergy in patients with failed metal-on-metal hip arthroplasty and peri-implant T-lymphocytic inflammation. Allergy (2009) 1.37

Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator. Circulation (1985) 1.34

Molecular-mechanical studies of the mismatched base analogs of d(CGCGAATTCGCG)2:d(CGTGAATTCGCG)2, d(CGAGAATTCGCG)2, d(CGCGAATTCACG)2, d(CGCGAATTCTCG)2, and d(CGCAGAATTCGCG).d(CGCGAATTCGCG). Biopolymers (1984) 1.30

EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy (2006) 1.28

Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. J Invest Dermatol (1996) 1.24

Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma. Br J Ophthalmol (2001) 1.23

Radioimmunoassay of 3 alpha-hydroxy-5 alpha-pregnan-20-one in rat and human plasma. Steroids (1990) 1.23

Is premenstrual dysphoric disorder a distinct clinical entity? J Womens Health Gend Based Med (1999) 1.21

[Hearing disorders in chronic kidney failure]. Monatsschr Ohrenheilkd Laryngorhinol (1972) 1.20

ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol (2009) 1.19

Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas. Br J Cancer (2008) 1.17

Recombinant type A and B phytochromes from potato. Transient absorption spectroscopy. Biochemistry (1997) 1.16

Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol (1999) 1.16

Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy (2014) 1.16

Localized reversible reduction of apparent diffusion coefficient in transient hypoglycemia-induced hemiparesis. Stroke (2005) 1.16

The use of routine laboratory data to predict in-hospital death in medical admissions. Resuscitation (2005) 1.15

Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis. Allergy (2005) 1.14

Intracellular pathways of copper trafficking in yeast and humans. Adv Exp Med Biol (1999) 1.11

Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years. J Vasc Surg (1994) 1.11

Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J Invest Dermatol (1991) 1.10

[Effect of BAY a 1040 on renal function in hypertension]. Arzneimittelforschung (1972) 1.10

55-kd tumor necrosis factor receptor is expressed by human keratinocytes and plays a pivotal role in regulation of human keratinocyte ICAM-1 expression. J Invest Dermatol (1991) 1.10

Cyclosporin in Wegener granulomatosis. Ann Intern Med (1988) 1.10

The vasodilator-stimulated phosphoprotein (VASP): target of YC-1 and nitric oxide effects in human and rat platelets. J Cardiovasc Pharmacol (2000) 1.10

Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI. Proc Natl Acad Sci U S A (1996) 1.10

Isolation of alpha-toxin-producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis. Br J Dermatol (2009) 1.09

Granulocyte-activating mediators (GRAM): I. Generation by lipopolysaccharide-stimulated mononuclear cells. J Invest Dermatol (1986) 1.09

Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB). Allergy (2000) 1.09

Identification of genetic evidence for dobrava virus spillover in rodents by nested reverse transcription (RT)-PCR and TaqMan RT-PCR. J Clin Microbiol (2005) 1.09

C5a suppresses the production of IL-12 by IFN-gamma-primed and lipopolysaccharide-challenged human monocytes. J Immunol (1999) 1.07

A mutation in the gene for the neurotransmitter receptor-clustering protein gephyrin causes a novel form of molybdenum cofactor deficiency. Am J Hum Genet (2000) 1.07

C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils. Eur J Immunol (1994) 1.06

Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group. Sleep Med (2013) 1.06

Histamine H4 receptors modulate dendritic cell migration through skin--immunomodulatory role of histamine. Allergy (2008) 1.05

Tumor necrosis factor beta and ultraviolet radiation are potent regulators of human keratinocyte ICAM-1 expression. J Invest Dermatol (1990) 1.05

C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins. Blood (1994) 1.05

Phorbol-12-myristate-13-acetate-treated human keratinocytes express B7-like molecules that serve a costimulatory role in T-cell activation. J Invest Dermatol (1993) 1.05

Modulation of human neutrophilic granulocyte functions by recombinant human tumor necrosis factor and recombinant human lymphotoxin. Promotion of adherence, inhibition of chemotactic migration and superoxide anion release from adherent cells. Clin Exp Immunol (1988) 1.04

NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272. BMC Pharmacol (2001) 1.04

Activated human T lymphocytes express a functional C3a receptor. J Immunol (2000) 1.04

Effect of renal transplantation on uremic deafness: a long-term study. Audiology (1977) 1.04

Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Eur J Immunol (1996) 1.04

[Acute renal failure following combined cephaloridine-gentamycin therapy (author's transl)]. Wien Klin Wochenschr (1973) 1.04

RNA metabolism and membrane-bound polysomes in relation to globulin biosynthesis in cotyledons of developing field beans (Vicia faba L.). Eur J Biochem (1979) 1.02

EAACI/GA2LEN position paper: present status of the atopy patch test. Allergy (2006) 1.02

Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med (1997) 1.02

Bacterial infections and atopic dermatitis. Allergy (2001) 1.02

High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol (1992) 1.02

The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation. J Clin Invest (1993) 1.01

Identification and localization of connexin26 within the photoreceptor-horizontal cell synaptic complex. Vis Neurosci (2001) 1.01